AR085116A1 - Compuestos heterociclicos como inhibidores de janus quinasa - Google Patents

Compuestos heterociclicos como inhibidores de janus quinasa

Info

Publication number
AR085116A1
AR085116A1 ARP120100338A ARP120100338A AR085116A1 AR 085116 A1 AR085116 A1 AR 085116A1 AR P120100338 A ARP120100338 A AR P120100338A AR P120100338 A ARP120100338 A AR P120100338A AR 085116 A1 AR085116 A1 AR 085116A1
Authority
AR
Argentina
Prior art keywords
alkyl
heteroaryl
aryl
nhr5
carboxyl
Prior art date
Application number
ARP120100338A
Other languages
English (en)
Spanish (es)
Inventor
Yarlagadda S Babu
Pravin L Kotian
Krishnan Raman
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of AR085116A1 publication Critical patent/AR085116A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP120100338A 2011-02-02 2012-02-02 Compuestos heterociclicos como inhibidores de janus quinasa AR085116A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161438932P 2011-02-02 2011-02-02

Publications (1)

Publication Number Publication Date
AR085116A1 true AR085116A1 (es) 2013-09-11

Family

ID=46603075

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120100338A AR085116A1 (es) 2011-02-02 2012-02-02 Compuestos heterociclicos como inhibidores de janus quinasa

Country Status (3)

Country Link
AR (1) AR085116A1 (zh)
TW (1) TW201309705A (zh)
WO (1) WO2012106448A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107739387B (zh) * 2017-10-16 2020-01-03 上海皓元生物医药科技有限公司 一种制备曲贝替定的关键中间体化合物的方法
WO2020161208A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2020161209A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2021121276A1 (zh) * 2019-12-17 2021-06-24 江苏恒瑞医药股份有限公司 稠合四环类衍生物、其制备方法及其在医药上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE465153T1 (de) * 2002-02-28 2010-05-15 Eisai R&D Man Co Ltd Neue indazolverbindungen mit kondensiertem ring
WO2007006566A1 (en) * 2005-07-12 2007-01-18 Abbott Gmbh & Co. Kg Pyridazine compounds as glycogen synthase kinase 3 inhibitors
EA016592B1 (ru) * 2007-03-13 2012-06-29 Биовитрум Аб (Пабл) Трициклические производные изохинолина для лечения ожирения
GB0718575D0 (en) * 2007-09-24 2007-10-31 Angeletti P Ist Richerche Bio Nucleoside derivatives as inhibitors of viral polymerases
TW201111385A (en) * 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors

Also Published As

Publication number Publication date
WO2012106448A1 (en) 2012-08-09
TW201309705A (zh) 2013-03-01

Similar Documents

Publication Publication Date Title
CO2017006214A2 (es) Derivados de quinazolina utilizados para tratar el vih
AR088175A1 (es) 3-pirimidin-4-il-oxazolidin-2-onas utiles para tratar cancer y composiciones farmaceuticas que las contienen
ECSP18094790A (es) Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas
SV2016005229A (es) Inhibidores de syk
PE20181093A1 (es) Compuestos heterociclicos y usos de los mismos
BR112017012755A2 (pt) compostos de heteroarila de anel fundido e seu uso como inibidores de trk
ECSP15035343A (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida útiles como inhibidores de quinasa pim
AR113909A1 (es) Compuestos y sus composiciones farmacéuticas para el tratamiento de hepatitis b
AR100137A1 (es) Compuestos 4-amino-imidazoquinolina
AR090760A1 (es) Compuestos de benzotiazol y su uso contra el virus de hiv
EA201690094A1 (ru) Ингибиторы syk
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
CR20190504A (es) COMPUESTO DE AMIDA (Divisional 2015-0454)
AR094964A1 (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRASTORNOS RELACIONADOS CON LA FOSFOINOSITIDA 3-CINASA d (PI3Kd)
CO6540003A2 (es) Inhibidor de bromodominio de benzodiazepina
CO6561783A2 (es) Inhibidores del virus flaviviridae
AR085960A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
AR108046A1 (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
BR112012017382A2 (pt) compostos inibidores de viroses flaviviridae, uso dos mesmos e composição farmacêutica
EA201491623A1 (ru) Замещенные пирролидин-2-карбоксамиды
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
TR201908265T4 (tr) Isı şok transkripsiyon faktörü 1 in inhibitörleri olarak kaynaşık 1,4-dihidrodioksin türevleri.
AR084731A1 (es) Derivados de imidazoquinolina sustituidos
DOP2016000308A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
AR098522A1 (es) Compuesto de triazolo-piridina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure